Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001645460-19-000002
Filing Date
2019-12-20
Accepted
2019-12-20 16:06:11
Documents
1
Effectiveness Date
2019-12-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13342
  Complete submission text file 0001645460-19-000002.txt   14578
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-356155 | Film No.: 191301350
SIC: 3845 Electromedical & Electrotherapeutic Apparatus